Outcomes in clinically relevant patient subgroups from the EMBRACA study: Talazoparib vs physician's choice standard-of-care chemotherapy
Hope S. Rugo*, Johannes Ettl, Sara A. Hurvitz, Anthony Gonçalves, Kyung Hun Lee, Louis Fehrenbacher, Lida A. Mina, Sami Diab, Natasha E. Woodward, Rinat Yerushalmi, Annabel Goodwin, Joanne L. Blum, Miguel Martin, Ruben G.W. Quek, Iulia Cristina Tudor, Helen Bhattacharyya, Eric Gauthier, Jennifer K. Litton, Wolfgang Eiermann
Research output: Contribution to journal › Article › peer-review
23Scopus
citations
Fingerprint
Dive into the research topics of 'Outcomes in clinically relevant patient subgroups from the EMBRACA study: Talazoparib vs physician's choice standard-of-care chemotherapy'. Together they form a unique fingerprint.